| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |